Total Funding
1
Total FundingDebt Financing raised
Growth Score
pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
2927810
Othera Pharmaceuticals is a a specialty pharmaceutical company, focuses on treatments for ophthalmic diseases.
Acquired by 
Colby Pharmaceutical
William Matier: Executive Vice President and Chief Science Officer- David Joseph: Chairman & CEO
About the Company
Othera Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on treatments for ophthalmic diseases. Its products include OT-551 for geographic atrophy/dry age-related macular degeneration; OT-730 a small molecule oculoselective beta-blocker for reducing the elevated intraocular pressure associated with glaucoma; and OT-440, a
neuroprotectant for glaucoma. The company was founded in 2002 and is headquartered in Exton, Pennsylvania.
